Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000643354 | SCV000765041 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000729143 | SCV000856785 | uncertain significance | not provided | 2017-09-06 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000729143 | SCV001879673 | uncertain significance | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477422 | SCV002779728 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-20 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000729143 | SCV003825614 | uncertain significance | not provided | 2022-06-27 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000729143 | SCV004225851 | uncertain significance | not provided | 2023-04-13 | criteria provided, single submitter | clinical testing |